Literature DB >> 2991150

The parenteral kinetics of ampicillin/sulbactam in man.

G Foulds, A K Knirsch, J P Stankewich, D R Weidler.   

Abstract

The kinetics of co-administered ampicillin plus sulbactam were examined at doses being used in clinical trials of this combination of a beta-lactam antibiotic (ampicillin) and a beta-lactamase inhibitor (sulbactam). Following 15-min infusion of 2 g ampicillin plus 1 g sulbactam, peak serum concentrations of 120 micrograms/ml ampicillin and 60 micrograms/ml sulbactam were observed. The half-life was approximately one hour for both drugs. Approximately 75% of the dose of sulbactam and ampicillin was recovered in urine. The data fit a two-compartment pharmacokinetic model. Intramuscular administration of 1 g ampicillin plus 0.5 g sulbactam produced mean peak concentrations of 18 micrograms/ml ampicillin plus 13 micrograms/ml sulbactam. Estimates of variability of the data in normal male subjects are provided to serve as references for clinical trials.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991150

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN: 0251-1649


  8 in total

1.  Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.

Authors:  R A Blum; R K Kohli; N J Harrison; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 2.  Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.

Authors:  D M Campoli-Richards; R N Brogden
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546

Review 3.  Systemic antibiotic therapy for chronic osteomyelitis in adults.

Authors:  Brad Spellberg; Benjamin A Lipsky
Journal:  Clin Infect Dis       Date:  2011-12-12       Impact factor: 9.079

Review 4.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

5.  Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis.

Authors:  Johan M Lorenzen; Michael Broll; Volkhard Kaever; Heike Burhenne; Carsten Hafer; Christian Clajus; Wolfgang Knitsch; Olaf Burkhardt; Jan T Kielstein
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

6.  Penetration of sulbactam and ampicillin into cerebrospinal fluid of infants and young children with meningitis.

Authors:  G Foulds; T J McBride; A K Knirsch; W J Rodriguez; W N Khan
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

7.  Comparative pharmacokinetics of sulbactam/ampicillin and clavulanic acid/amoxycillin in human volunteers.

Authors:  B Hampel; H Lode; G Bruckner; P Koeppe
Journal:  Drugs       Date:  1988       Impact factor: 9.546

8.  Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to sheep.

Authors:  E Escudero; A Espuny; S Vicente; C M Cárceles
Journal:  Can J Vet Res       Date:  1999-01       Impact factor: 1.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.